ISLET HOLDINGS FILES AMENDED COMPLAINT AGAINST ISLET SCIENCES, INC. [OTCBB: ISLT]

In Setback for Diabetes Research New Allegations of Conspiracy and Racketeering Surface as Dr. Jonathan Lakey and Charles Daniel Rhodes Added as New Defendants.

Salt Lake City, UT:  July 19, 2013.  New allegations of conspiracy and racketeering and a written confession from a scheme participant have led to the resignation of CEO John Steel and the restructuring of management at Islet Sciences, Inc. (OTCBB:ISLT). The restructuring was announced after an amended complaint was filed in federal court charging that Islet Sciences has been enticing investment using false documents, and that Steel has “made numerous threats against anyone related to Isletech.”

The litigation was brought by Islet Holdings, Inc., and its subsidiary Isletech, Inc., against Islet Sciences Inc.; CEO John Steel; Islet Sciences director Dr. Jonathan Lakey; and Charles Daniel (“Dan”) Rhodes.  According to Salt Lake attorney Marcus Mumford, who is representing Islet Holdings and Isletech in the lawsuit, the new complaint includes a confession from Mr. Rhodes admitting his participation in a fraud scheme orchestrated by Steel on behalf of Islet Sciences. In his confession, Rhodes describes how Isletech purchased intellectual property out of the MicroIslet, Inc., bankruptcy proceedings in 2009 but that Steel later “lied” and said that it had been purchased by someone else.  Steel later purported to transfer the MicroIslet property to Islet Sciences, which has been “building off the patents and intellectual property of MicroIslet” ever since.  The amended federal complaint also alleges claims for violations of the Racketeer Influenced And Corrupt Organizations Act (Civil RICO) and theft. 

Islet Sciences, Inc. has claimed the intellectual property in filings with the SEC as part of its ongoing development of technologies for infusion therapy for insulin-dependent diabetes, including methods for culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells.  The lawsuit seeks a declaratory judgment to establish the ownership of the critical MicroIslet patents and intellectual property and damages for patent infringement. 

The case is Islet Holdings, Inc., et al. v. Islet Sciences, Inc., et al., Case No. 2:12-cv-00799-RJS (D. Utah) where the federal judge assigned to the case has queried whether anyone reported the alleged activities to the enforcement arm for the SEC.  As part of his firm’s continuing investigation, Mumford encourages all persons with information related to wrongdoing at Islet Sciences to contact MUMFORD PC.

Company Name: MUMFORD PC
Contact Person: Marcus Mumford
Email: Send Email
Phone: 810-428-2000
City: Salt Lake City
State: UT
Country: United States
Website: http://www.nolo.com/lawyers/law-firm/mumford-and-rawson-6681.html


Source: www.abnewswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.